Evaluation of blood components exposed to coated arterial filters in extracorporeal circuits

Perfusion

Volumn 24, Issue 5, 2009, Pages 317-323

  Hussaini, Bader E ^a   Treanor, Patrick R ^a   Healey, Nancy A ^a   Tilahun, Daniel ^a   Srey, Rithy ^a   lu, Xiu Gui ^a   Khuri, Shukri F ^b   Thatte, Hemant S ^c  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

arterial filters; blood component; extracorporeal circulation; hemocompatibility; heparin bonded circuit

Indexed keywords

BIOMATERIAL; HEPARIN;

ANIMAL; ANIMAL MODEL; ARTICLE; CARDIOPULMONARY BYPASS; CHEMISTRY; EVALUATION; EXTRACORPOREAL CIRCULATION; FILTRATION; MALE; SURFACE PROPERTY; SWINE;

ANIMALS; CARDIOPULMONARY BYPASS; COATED MATERIALS, BIOCOMPATIBLE; EXTRACORPOREAL CIRCULATION; FILTRATION; HEPARIN; MALE; MODELS, ANIMAL; SURFACE PROPERTIES; SWINE;

EID: 77950353860     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659109353818     Document Type: Article

References (26)

1. Khuri SF, Wolf JA, Josa M., et al. Hematological changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992; 104: 94-107.
2. Fukutomi M., Kobayashi S., Niwaya K., Hamada Y., Kitamura S. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment. Artif Organs 1996; 20: 767-776.
3. Colman RW Hemostatic complications of cardiopulmonary bypass. Am J Hematol 1995; 48: 267-272.
4. Laffey JG, Boylan, JF, Cheng DC The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215-252.
5. Cremer J., Martin M., Redl H., et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996; 61: 1714-1720.
6. Kirklin JK, Westaby S., Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845-857.
7. Lappegard KT, Fung M., Bergseth G., Riesenfeld J., Mollnes TE Artificial surface-induce cytokine synthesis: effect of heparin coating and complement inhibition. Ann Thorac Surg 2004; 78: 38-45.
8. Moen O., Høgåsen K., Fosse E., et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997 ;63: 105-111.
9. Aldea GS, O'Gara P., Shapira OM et al. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. Ann Thorac Surg 1998; 65: 425-433.
10. Mahoney CB Heparin-bonded circuits: clinical outcomes and costs. Perfusion 1998; 13: 192-204.
11. Jessen ME Pro: Heparin-coated circuits should be used for cardiopulmonary bypass. Anesthesia & Analgesia 2006; 103: 1365-1369.
12. Wendel HP, Zimmer G. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 1999; 16: 342-350.
13. Gong J., Larsson R., Ekdahl KN, Mollnes TE, Nilsson U., Nilsson B. Tubing loops as a model for cardiopulmonary bypass circuits: both the biomaterial and the blood-gas phase interfaces induce complement activation in an in vitro model. J Clin Immunol 1996; 16: 222-229.
14. Kiessling AH, Khalil M., Assaf O., Isgro F., Kertz KU, Saggau W. Blood-air interface during cardiopulmonary bypass. Asian Cardiovasc Thorac Ann 2004; 12: 198-201.
15. De Somer F. Optimization of the perfusion circuit and its possible impact on the inflammatory response. J Extra Corpor Technol 2007; 39: 285-288.
16. Hsu LC Biocompatibility in cardiopulmonary bypass. J Cardiothorac Vasc Anesthes 1997; 11: 376-382.
17. Saito N., Motoyama S., Sawamoto J. et al. Effect of new polymer-coated extracorporeal circuit biocompatibility during cardiopulmonary bypass. Artificial Organs 2000; 24: 547-554.
18. Ninomiya M., Brady CP, Christensen KA, et al. Influence of PMEA-coated bypass circuits on perioperative inflammatory response. Ann Thorac Surg 2003; 75: 913-918.
19. Noguchi M., Eishi K., Tada S., et al. Biocompatibility of poly2methoxythylacrylate-coating for cardiopulmonary bypass. Ann Thorac Cardiovasc Surg 2003; 9: 22-28.
20. Thatte HS, Biswas KS, Najjar SF, et al. Multi-photon microscopic evaluation of saphenous vein endothelium and its preservation with a new solution, GALA. Ann Thorac Surg 2003; 75: 1145-1152.
21. Biswas K., Thatte H., Najjar S., et al. Multi-photon microscopy in the evaluation of human saphenous vein. J Surg Res 2001; 95: 37-43.
22. Dygert JH, Thatte HS Kumbhani DJ, Najjar SF, Treanor PR, Khuri SF Intracoronary shunt induced endothelial cell damage in porcine heart. J Surg Res 2006; 131: 168-174.
23. Rousou LJ, Taylor K., Lu XG, et al. Saphenous vein conduits harvested by endoscopic technique exhibit structural and functional damage. Ann Thorac Surg 2009; 87: 62-70.
24. Engler RL, Schmid-Schönbein GW, Pavelec RS Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog. Am J Pathol 1983; 111: 98-111.
25. Bando K., Pillai R., Cameron DE, et al. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99: 873-877.
26. Hachida M., Hanayama N., Okamura T., et al. The role of leukocyte depletion in reducing injury to myocardium and lung during cardiopulmonary bypass. ASAIO J 1995; 41: M291-M294.